These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 25520363)

  • 1. Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.
    Van Aelst LN; Voss S; Carai P; Van Leeuwen R; Vanhoutte D; Sanders-van Wijk S; Eurlings L; Swinnen M; Verheyen FK; Verbeken E; Nef H; Troidl C; Cook SA; Brunner-La Rocca HP; Möllmann H; Papageorgiou AP; Heymans S
    Circ Res; 2015 Jan; 116(3):425-36. PubMed ID: 25520363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
    Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
    J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation.
    Deckx S; Heggermont W; Carai P; Rienks M; Dresselaers T; Himmelreich U; van Leeuwen R; Lommen W; van der Velden J; Gonzalez A; Diez J; Papageorgiou AP; Heymans S
    Matrix Biol; 2018 Mar; 66():110-124. PubMed ID: 28958774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for decorin in the remodeling of myocardial infarction.
    Weis SM; Zimmerman SD; Shah M; Covell JW; Omens JH; Ross J; Dalton N; Jones Y; Reed CC; Iozzo RV; McCulloch AD
    Matrix Biol; 2005 Jun; 24(4):313-24. PubMed ID: 15949932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
    Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction.
    Fang L; Gao XM; Samuel CS; Su Y; Lim YL; Dart AM; Du XJ
    Clin Sci (Lond); 2008 Aug; 115(3):99-106. PubMed ID: 18248324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in TIMP-3 increases cardiac rupture and mortality post-myocardial infarction via EGFR signaling: beneficial effects of cetuximab.
    Hammoud L; Lu X; Lei M; Feng Q
    Basic Res Cardiol; 2011 May; 106(3):459-71. PubMed ID: 21243368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction.
    Schellings MW; Vanhoutte D; Swinnen M; Cleutjens JP; Debets J; van Leeuwen RE; d'Hooge J; Van de Werf F; Carmeliet P; Pinto YM; Sage EH; Heymans S
    J Exp Med; 2009 Jan; 206(1):113-23. PubMed ID: 19103879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice.
    Cavasin MA; Tao Z; Menon S; Yang XP
    Life Sci; 2004 Sep; 75(18):2181-92. PubMed ID: 15325844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction.
    Vanhoutte D; Schellings MW; Götte M; Swinnen M; Herias V; Wild MK; Vestweber D; Chorianopoulos E; Cortés V; Rigotti A; Stepp MA; Van de Werf F; Carmeliet P; Pinto YM; Heymans S
    Circulation; 2007 Jan; 115(4):475-82. PubMed ID: 17242279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matricellular protein CCN1 promotes collagen alignment and scar integrity after myocardial infarction.
    Fischer AG; Elliott EM; Brittian KR; Garrett L; Sadri G; Aebersold J; Singhal RA; Nong Y; Leask A; Jones SP; Moore Iv JB
    Matrix Biol; 2024 Nov; 133():14-32. PubMed ID: 39098433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function.
    Virag JA; Rolle ML; Reece J; Hardouin S; Feigl EO; Murry CE
    Am J Pathol; 2007 Nov; 171(5):1431-40. PubMed ID: 17872976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels.
    Huang W; Rubinstein J; Prieto AR; Wang DH
    J Hypertens; 2010 Feb; 28(2):367-76. PubMed ID: 19887954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
    Zaidi SH; Huang Q; Momen A; Riazi A; Husain M
    J Am Coll Cardiol; 2010 Jan; 55(2):135-43. PubMed ID: 20117381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.
    Nawaito SA; Sahadevan P; Clavet-Lanthier MÉ; Pouliot P; Sahmi F; Shi Y; Gillis MA; Lesage F; Gaestel M; Sirois MG; Calderone A; Tardif JC; Allen BG
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1281-H1296. PubMed ID: 30901279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction.
    Matsui Y; Ikesue M; Danzaki K; Morimoto J; Sato M; Tanaka S; Kojima T; Tsutsui H; Uede T
    Circ Res; 2011 May; 108(11):1328-39. PubMed ID: 21493899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.